Analyst estimates
Stock Information
| Price (Prev Close) | 988.00 |
| Price - 52 Week High | 1,224.00 |
| Price - 52 Week Low | 839.00 |
| Price Date (Latest) | Jun 27, 2017 |
| Median Price Target | 6,253.57 |
| Diff from Prev Close | -47.50 |
| % Difference | -4.81% |
Analyst Ratings
| 1 Strong Buy | 1 |
| 2 Buy | 0 |
| 3 Hold | 2 |
| 4 Underperform | 1 |
| 5 Sell | 3 |
Mean Recommendation: 3.71
Reference Information
| Last Actual (FY0) | 33.59 |
| FY0 End Date | Dec '16 |
| Indicated Annual Div. | 5.00 |
| Hist (5 Yr) Growth % | 18.26 % |
| Hist (5 Yr) Stability % | 40.19 % |
| Yield (%) | 0.51 % |
Analyst Forecasts
| Fiscal Period | Mean | High | Low | Median | # of Estimates | # Up | # Down | Mean % Change | |
|---|---|---|---|---|---|---|---|---|---|
| Annual Dec '19 |
30.90 | 40.30 | 17.95 | 32.67 | 4 | 0 | 1 | -1.63 % | |
| Annual Dec '18 |
21.88 | 28.90 | 10.06 | 24.27 | 4 | 0 | 1 | -4.20 % | |
| Annual Dec '17 |
7.82 | 12.30 | 3.35 | 7.82 | 2 | 0 | 1 | -9.88 % | |
| Quarterly Jun '17 |
1.30 | 1.30 | 1.30 | 1.30 | 1 | 0 | 0 | - | |
| Quarterly Sep '17 |
0.20 | 0.20 | 0.20 | 0.20 | 1 | 0 | 0 | - | |
| Quarterly Dec '17 |
3.96 | 6.90 | 2.17 | 2.80 | 3 | 0 | 0 | - | |
| Long Term Growth N/A |
12.40 | 12.40 | 12.40 | 12.40 | 1 | 0 | 0 | - | |
Actuals
| Fiscal Period | Reported EPS | Mean Estimates | Surprise % Change |
|---|---|---|---|
| Annual Dec '16 |
33.59 | 31.18 | 7.72 % |
| Quarterly Jun '16 |
7.78 | 3.15 | 146.98 % |
| Quarterly Sep '16 |
5.00 | 2.80 | 78.57 % |
| Quarterly Dec '16 |
6.79 | 3.30 | 105.76 % |
| Quarterly Mar '17 |
0.00 | 5.45 | -100.00 % |
| Annual Dec '15 |
35.05 | 23.71 | 47.83 % |
| Annual Dec '14 |
22.71 | 23.04 | -1.43 % |
P/E Ratios
ALK - eafe health care
| Fiscal Period | ALK | eafe health care | Industry Relative |
|---|---|---|---|
| FY0 | 29.41 | 24.04 | 1.22 |
| FY1 | 126.26 | 22.17 | 5.69 |
| FY2 | 45.16 | 19.63 | 2.30 |
EPS Growth Rates
ALK - eafe health care
| Growth Rates | ALK | eafe health care | Industry Relative |
|---|---|---|---|
| FY1/FY0 | -76.70 | 8.62 | 0.21 |
| FY2/FY1 | 179.59 | 12.95 | 2.48 |
| FY3/FY2 | 41.22 | 9.88 | 1.29 |
Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover ALK. Please note that any opinions, estimates or forecasts regarding ALK's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of ALK or its management. ALK does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Prices are in DKK